Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection. (Q34462097)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741696%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741696%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741696%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

G Webster

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741696%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741696%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741696%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741696%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741696%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

467-473

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741696%20AND%20SRC:MED&resulttype=core&format=json

Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Quantifying the uncertainty in forecasts of anthropogenic climate change

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Initial and innate responses to viral infections--pattern setting in immunity or disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Cytotoxic T cells and viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Cutting edge: lipid raft integrity affects the efficiency of MHC class I tetramer binding and cell surface TCR arrangement on CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Towards a rational therapy for hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Long-lasting memory T cell responses following self-limited acute hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Specific vaccine therapy in chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Efficacy and limitations of a specific immunotherapy in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

A T cell-dependent experimental liver injury in mice inducible by concanavalin A

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Assessing CD8 T cell number and dysfunction in the presence of antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900082-7

7 January 2021

10.1016/S0161-5890(01)00082-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11741696%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference